Creative medical technology announces $2 million share repurchase program

Phoenix , june 12, 2023 /prnewswire/ -- creative medical technology holdings, inc. ("creative medical technology" or the "company") (nasdaq: celz), a biotechnology company focused on a regenerative approach to immunotherapy, endocrinology, urology, gynecology, and orthopedics, today announced that its board of directors has approved a share repurchase program. the program authorizes the company to repurchase up to $2 million of its shares of common stock, in the open market or through privately negotiated transactions, in accordance with applicable securities laws and other restrictions.
CELZ Ratings Summary
CELZ Quant Ranking